Dr. Reddy’s reaches settlement regarding Consumer Product Safety Act compliance
It has been announced by the United States subsidiary of Dr. Reddy’s Laboratories, that the company has reached a settlement with the U.S. Government in a case involving packaging for five blister-packed prescription products.
In a joint filing, both parties have agreed to a settlement of the action without any adjudication or issue of fact or law. The matter has been settled for $5 million dollars, and the product in question has not been distributed in the packaging at issue since June 2012, the company said.
The company also said that it is not aware of any reports that a child gained access to the products as a result of the packaging, or that the products have caused harm to a child as a result of the packaging. Dr. Reddy’s said that it is committed to complying with all applicable requirements of the Consumer Product Safety Act, which includes applicable packaging and reporting requirements.
In a joint filing, both parties have agreed to a settlement of the action without any adjudication or issue of fact or law. The matter has been settled for $5 million dollars, and the product in question has not been distributed in the packaging at issue since June 2012, the company said.
The company also said that it is not aware of any reports that a child gained access to the products as a result of the packaging, or that the products have caused harm to a child as a result of the packaging. Dr. Reddy’s said that it is committed to complying with all applicable requirements of the Consumer Product Safety Act, which includes applicable packaging and reporting requirements.